Intra-tumour genetic heterogeneity and poor chemoradiotherapy response in cervical cancer
2011

Genetic Heterogeneity in Cervical Cancer

Sample size: 10 publication 10 minutes Evidence: moderate

Author Information

Author(s): Cooke S L, Temple J, MacArthur S, Zahra M A, Tan L T, Crawford R A F, Ng C K Y, Jimenez-Linan M, Sala E, Brenton J D

Primary Institution: Cancer Research UK Cambridge Research Institute

Hypothesis

Does intra-tumour genetic heterogeneity affect chemoradiotherapy response in cervical cancer?

Conclusion

Genetic heterogeneity in advanced cervical cancers may predict poor treatment outcomes.

Supporting Evidence

  • Three patients had distinct genetic subpopulations before treatment.
  • Genetic changes were observed in response to chemoradiotherapy.
  • Patients with heterogeneous tumours had shorter survival times.

Takeaway

Cervical cancer can have different types of cells that respond differently to treatment, which can make it harder to treat.

Methodology

The study analyzed biopsies from 10 cervical cancer patients at multiple time points during treatment to assess genetic changes.

Limitations

The study had a small sample size and may not represent all cervical cancer cases.

Participant Demographics

Patients were recruited from a clinical study, with a mix of squamous cell carcinoma and adenocarcinoma types.

Digital Object Identifier (DOI)

10.1038/sj.bjc.6605971

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication